Exciva

London, United Kingdom Founded: 2015 • Age: 11 yrs
Digital clinical care management tool for Alzheimers disease

About Exciva

Exciva is a Healthcare company based in London (United Kingdom) founded in 2015 by Anton Bespalov. It operates as a digital clinical care management tool for Alzheimers disease. Exciva has raised $69.79 million across 2 funding rounds from investors including Andera Partners, LBBW Venture Capital and Cure8. Exciva offers products and services including Therapy for Neuropsychiatric Symptoms. Its focus areas include HealthTech, Healthcare IT, Value Based Care and Care Coordination. Its legal entity is EXCIVA GmbH. Its competitors include Eleanor Health, Monsenso, Eleos Health, YNMODATA and Owl and 2 more; 6 of its 7 listed competitors have raised funding.

Company details

Exciva was founded in 2015 in London, United Kingdom, as a health technology company. A digital platform is provided for clinical care management targeted at Alzheimers disease. Operations are based in the UK, where services support care coordination and monitoring for patients. Anton Bespalov is listed as Co-Founder and Managing Director, overseeing development and strategy in the neurodegenerative disease sector.

  • Headquarters London, United Kingdom
  • Founders Anton Bespalov
  • Sectors
    Healthcare
  • Website exciva.com
  • Social LinkedIn
  • Legal Name Exciva Gmbh
Key Metrics
  • Total Equity Funding
    $69.79M (USD)

    in 2 rounds

  • Latest Funding Round
    $59.32M (USD), Series B

    Jan 2026

  • Investors

Products & Services of Exciva

Exciva offers a comprehensive portfolio of products and services, including Therapy for Neuropsychiatric Symptoms.

Therapy for Neuropsychiatric Symptoms
Medical Treatment

Develops treatments targeting agitation in Alzheimer's disease patients

Funding Insights of Exciva

Exciva has successfully raised a total of $69.79M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $59.32 million completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $69.79M
  • Total Rounds 2
  • Last Round Series B β€” $59.32M
  • First Round $10.46M

    (Oct 2021)

  • Investors Count 9

All 2 funding rounds of Exciva with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2026$59.32MSeries B–EQT
Oct 2021$10.46MSeries A–Andera Partners
Valuation history

9 investors in total: 9 institutional.

Investors in Exciva

Exciva has secured backing from 9 investors, including venture fund investors. Prominent investors backing the company include Andera Partners, LBBW Venture Capital and Cure8.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Capital is provided to firms for growth, buyouts, and acquisitions.
2001anderapartners.comParis, France
Early-stage VC firm investing in smart & deep-tech, fin-tech and life science & health-tech sectors
–lbbwvc.deStuttgart, Germany
-
–eqtgroup.com-
-
–gimv.com-
-
–fh-partners.com-
-
–lifearcventures.com-
-
–carma-fund.com-
-
–modivc.com-
-
–cure8.tech-
Premium access

Investor details for Exciva

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Exciva

3 people are tracked at Exciva (3 in leadership).

NameRoleGroup
Anton Bespalov
Co-Founder & Managing DirectorLeadership
Jina Swartz MD, PhD, MScMed(Neuro), MFPM(Dis), FMedSci
Chief Medical OfficerLeadership
Francisco Orellana
Chief Financial OfficerLeadership
Premium access

Complete people profiles for Exciva

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Exciva

3 dated milestones of Exciva across 11 years, from founding to its latest funding, stage changes and deals.

  1. Founded Exciva is founded.
  2. Funding First funding round of $10.5M.
  3. Funding Latest funding round, Series B, of $59.3M.

Competitors of Exciva

Exciva has 7 listed competitors in our database, 6 of them funded. They include Eleanor Health, Monsenso, Eleos Health, YNMODATA and Owl, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
eleanorhealth.com2019Waltham, United States$165.94M–
Chain of addiction and mental health treatment centers
monsenso.com2013Copenhagen, Denmark$4.18M20
Provider of an e-health platform for mental illness treatment and patient engagement
eleos.health2019Boston, United States$126M–
AI-based behavioral health diagnosis and management system for providers
ynmodata.com2016Taif, Saudi Arabia$5.5M–
Care management solutions for special needs patients are developed.
owl.health2013Portland, United States––
Cloud-based software for value-based healthcare care is provided to providers.
ehave.com2011Toronto, Canada$606,903–
Mental health treatment plans are created via a cloud-based platform.
trayt.health2014Palo Alto, United States$44,999–
AI-based clinical decision support platform for neurologists
Premium access

Detailed competitors of Exciva

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Clinical IT & Data Platforms

10 companies that operate in the same segment as Exciva (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts
2016Bengaluru, Karnataka, IndiaUSD 716.99 M–1,832
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M––
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M–1,746
Tech-enabled mental health solutions for employers are provided.
2016New York, New York, United StatesUSD 473.73 M–3,902
App-based health insurance is offered to individuals and businesses.
2016Paris, Ile de France, FranceUSD 863.12 M–1,606
Virtual care programs for managing chronic diseases are provided.
2011San Francisco, California, United StatesUSD 450.12 MUSD 260.21 M992
AI-driven EMR and practice management software is delivered for clinics.
2010Boca Raton, Florida, United StatesUSD 329.17 M–2,470
Cloud-based administrative tools for healthcare providers are offered.
1997Watertown, United StatesUSD 40 M––
Membership-based primary care platform is offered for employees and consumers.
2007San Francisco, California, United StatesUSD 402.56 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Exciva

Exciva was founded in 2015 and raised its 1st funding round 6 years after it was founded.

Exciva is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.

Exciva is a funded company, having raised a total of $69.79M across 2 funding rounds to date. The company's 1st funding round was a Series A of $10.46M, raised on Oct 2021.

Exciva was founded in 2015 in London, United Kingdom, as a health technology company. A digital platform is provided for clinical care management targeted at Alzheimers disease. Operations are based in the UK, where services support care coordination and monitoring for patients. Anton Bespalov is listed as Co-Founder and Managing Director, overseeing development and strategy in the neurodegenerative disease sector.

Exciva's top competitors include Eleanor Health, Eleos Health and YNMODATA.

Exciva offers Therapy for Neuropsychiatric Symptoms.

Exciva has 9 investors. Key investors include Andera Partners, LBBW Venture Capital, Cure8, EQT, and Gimv.

Exciva operates through Exciva Gmbh.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available